LFB USA, a leading biopharmaceutical firm, is a unit of France’s LFB Group. Located on Crowley Drive, the $37 million facility will produce the drug ATryn used in the treatment of preeclampsia, a leading cause of maternal and infant death. The 70,000 SF facility will house 30,000 SF of clean room manufacturing space, 20,000 SF of warehouse space, and 14,000 SF of office space. A distinct modern aesthetic was designed for the building’s exterior.